Why did Lisata acquire Marea with a $225 million financing package?

Lisata’s acquisition of Marea paired the deal with $225 million in financing to back development of two medicines already in mid-stage testing. The article says the setup gives investors a cleaner, well-capitalized vehicle focused on cardiovascular and endocrine programs, putting Marea’s pipeline story in front of Wall Street.